NEU 1.54% $19.86 neuren pharmaceuticals limited

Ann: DAYBUE (trofinetide) launched in US - Neuren earns US$40m, page-35

  1. 256 Posts.
    lightbulb Created with Sketch. 21
    Have you held these shares since approx. 2011?
 
watchlist Created with Sketch. Add NEU (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.